Regulation of HBV-specific CD8+ T cell-mediated inflammation is diversified in different clinical presentations of HBV infection|RISS 상세보기

다국어 초록 (Multilingual Abstract)

Chronic HBV infection is the leading cause of liver cirrhosis and hepatic cancer, but the individual responses toward HBV infection are highly variable, ranging from asymptomatic to chronic active hepatitis B inflammation. In this study, we hypothesized that the different individual responses to HBV infection was associated with differences in HBV-specific CD8+ T cell-mediated inflammation and cytotoxicity. Blood samples were collected from subjects with asymptomatic HBV-infection, subjects undergoing active chronic HBV flares (active CHB), and subjects with HBV-infected hepatocellular carcinoma (HBV-HCC). By tetramer staining, we found that all three groups had similar frequencies of HBVspecific CD8+ T cells. However, after HBV peptide stimulation, the HBV-specific CD8+ T cells in asymptomatic subjects had significantly stronger interferon gamma (IFN-γ), tumor necrosis factor alpha (TNF-α), and CD107a expression than those in active CHB and HBV-HCC patients.
Examination of surface marker expression revealed that the PD-1-Tim-3- double-negative cell population was the main contributor to HBV-specific inflammation. In active CHB patients and HBV-HCC patients, however, the frequencies of activated PD-1-Tim-3- cells were significantly reduced.
Moreover, the serum HBV DNA titer was not correlated with the frequencies of HBV-specific CD8+ T cells but was inversely correlated with the frequencies of IFN-g-expressing and CD107a-express cells in response to HBV stimulation.
Together, our data demonstrated that the status of HBVspecific CD8+ T cell exhaustion was associated with different clinical outcomes of chronic HBV infection.

번역하기

참고문헌 (Reference)

1 Nebbia, G., "Upregulation of the Tim-3/Galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection" 7 : e47648-, 2012

2 Boni, C., "Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B" 39 : 595-605, 2003

3 Diehl, L., "Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8+T cell tolerance" 47 : 296-305, 2007

4 Wu, W., "Tim-3expression on peripheral T cell subsets correlates with disease progression in hepatitis B infection" 8 : 113-, 2011

5 Li, H., "Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma" 56 : 1342-1351, 2012

6 Anderson, A.C., "Tim-3, a negative regulator of anti-tumor immunity" 24 : 213-216, 2012

7 Moorman, J.P., "Tim-3 pathway controls regulatory and effector T cell balance during hepatitis C virus infection" 189 : 755-766, 2012

8 McMahan, R.H., "Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity" 120 : 4546-4557, 2010

9 Jones, R.B., "Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection" 205 : 2763-2779, 2008

10 Maini, M.K., "The role of virus-specific CD8+ cells in liver damage and viral control during persistent hepatitis B virus infection" 191 : 1269-1280, 2000